Contemporary estrogen-progestin contraceptives are associated with an increased risk for ischemic stroke and myocardial infarction.
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback